Research ArticleArticle
Open Access
Reliability of the Pediatric Specific Musculoskeletal Ultrasound Scoring Systems for the Elbow, Wrist, and Finger Joints
Patricia Vega-Fernandez, Ysabella Esteban, Edward Oberle, Jean-Philippe Proulx-Gauthier, Matthew Clark, Susan Shenoi, Akaluck Thatayatikom, Heather Benham, Emily J. Brunner, Leandra Woolnough, Michael Henrickson, Laura R. Pratt, Deirdre De Ranieri, Sarah Hoffmann, Ginger Janow, Hulya Bukulmez, Mekibib Altaye, Amy Cassedy, Tracy V. Ting and Johannes Roth on behalf of CARRA JIA Ultrasound Workgroup
The Journal of Rheumatology October 2022, jrheum.220382; DOI: https://doi.org/10.3899/jrheum.220382
Patricia Vega-Fernandez
The authors wish to acknowledge Childhood Arthritis and Rheumatology Research Alliance (CARRA) and the ongoing Arthritis Foundation financial support of CARRA. This project was funded by a CARRA–Arthritis Foundation Small Grant. PVF was supported by the Center for Clinical and Translational Science and Training at the University of Cincinnati, which is funded by the National Institutes of Health (NIH) Clinical and Translational Science Award program (grant 2UL1TR001425-05A1 and KL2 [2KL2TR001426-05A]); the National Institutes of Arthritis and Musculoskeletal Skin Diseases (award no. P30AR076316); and the Diversity and Health Disparities Award, which is funded by Cincinnati Children's Hospital Medical. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. P. Vega-Fernandez, MD, MSc, Y. Esteban, MD, M. Henrickson, MD, MPH, T.V. Ting, MD, MSc, Department of Pediatrics, University of Cincinnati, Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; E. Oberle, MD, Nationwide Children's Hospital, Columbus, Ohio, USA; J.P. Proulx-Gauthier, MD, FRCPC, Department of Pediatrics, CHU de Québec-Université Laval, Quebec City, Quebec, Canada; M. Clark, MD, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA; S. Shenoi, MBBS, MS, Seattle Children's Hospital and Research Center University of Washington, Seattle, Washington, USA; A. Thatayatikom, MD, AdventHealth for Children, Orlando, Florida, USA; H. Benham, DNP, APRN, Scottish Rite for Children Dallas, Dallas, Texas, USA; E.J. Brunner, DO, Geisinger Medical Center, Danville, Pennsylvania, USA; L. Woolnough, MD, MSCS, Department of Pediatrics, UFHealth, Gainesville, Florida, USA; L.R. Pratt, MD, University of Nebraska Medical Center, Omaha, Nebraska, USA; D. De Ranieri, MD, Department of Pediatrics, Northwestern Feinberg School of Medicine, Division of Rheumatology, Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois, USA; S. Hoffmann, MD, Children's Hospital of Richmond, Virginia, USA; G. Janow, MD, MPH, Joseph M. Sanzari Children's Hospital, Hackensack, New Jersey, USA; H. Bukulmez, MD, Department of Pediatrics, Division of Pediatric Rheumatology, Metro Health Medical System, Case Western Reserve University, Cleveland, Ohio, USA; M. Altaye, PhD, A. Cassedy, PhD, Department of Pediatrics, University of Cincinnati, Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; J. Roth, MD, PhD, FRCPC, Children's Hospital Eastern Ontario, Ottawa, Ontario, Canada. Address correspondence to Dr. P. Vega-Fernandez, 3333 Burnet Ave, Cincinnati, OH 45229, USA. Email: patricia.vegafernandez@cchmc.org. Accepted for publication September 13, 2022.
Ysabella Esteban
The authors wish to acknowledge Childhood Arthritis and Rheumatology Research Alliance (CARRA) and the ongoing Arthritis Foundation financial support of CARRA. This project was funded by a CARRA–Arthritis Foundation Small Grant. PVF was supported by the Center for Clinical and Translational Science and Training at the University of Cincinnati, which is funded by the National Institutes of Health (NIH) Clinical and Translational Science Award program (grant 2UL1TR001425-05A1 and KL2 [2KL2TR001426-05A]); the National Institutes of Arthritis and Musculoskeletal Skin Diseases (award no. P30AR076316); and the Diversity and Health Disparities Award, which is funded by Cincinnati Children's Hospital Medical. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. P. Vega-Fernandez, MD, MSc, Y. Esteban, MD, M. Henrickson, MD, MPH, T.V. Ting, MD, MSc, Department of Pediatrics, University of Cincinnati, Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; E. Oberle, MD, Nationwide Children's Hospital, Columbus, Ohio, USA; J.P. Proulx-Gauthier, MD, FRCPC, Department of Pediatrics, CHU de Québec-Université Laval, Quebec City, Quebec, Canada; M. Clark, MD, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA; S. Shenoi, MBBS, MS, Seattle Children's Hospital and Research Center University of Washington, Seattle, Washington, USA; A. Thatayatikom, MD, AdventHealth for Children, Orlando, Florida, USA; H. Benham, DNP, APRN, Scottish Rite for Children Dallas, Dallas, Texas, USA; E.J. Brunner, DO, Geisinger Medical Center, Danville, Pennsylvania, USA; L. Woolnough, MD, MSCS, Department of Pediatrics, UFHealth, Gainesville, Florida, USA; L.R. Pratt, MD, University of Nebraska Medical Center, Omaha, Nebraska, USA; D. De Ranieri, MD, Department of Pediatrics, Northwestern Feinberg School of Medicine, Division of Rheumatology, Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois, USA; S. Hoffmann, MD, Children's Hospital of Richmond, Virginia, USA; G. Janow, MD, MPH, Joseph M. Sanzari Children's Hospital, Hackensack, New Jersey, USA; H. Bukulmez, MD, Department of Pediatrics, Division of Pediatric Rheumatology, Metro Health Medical System, Case Western Reserve University, Cleveland, Ohio, USA; M. Altaye, PhD, A. Cassedy, PhD, Department of Pediatrics, University of Cincinnati, Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; J. Roth, MD, PhD, FRCPC, Children's Hospital Eastern Ontario, Ottawa, Ontario, Canada. Address correspondence to Dr. P. Vega-Fernandez, 3333 Burnet Ave, Cincinnati, OH 45229, USA. Email: patricia.vegafernandez@cchmc.org. Accepted for publication September 13, 2022.
Edward Oberle
The authors wish to acknowledge Childhood Arthritis and Rheumatology Research Alliance (CARRA) and the ongoing Arthritis Foundation financial support of CARRA. This project was funded by a CARRA–Arthritis Foundation Small Grant. PVF was supported by the Center for Clinical and Translational Science and Training at the University of Cincinnati, which is funded by the National Institutes of Health (NIH) Clinical and Translational Science Award program (grant 2UL1TR001425-05A1 and KL2 [2KL2TR001426-05A]); the National Institutes of Arthritis and Musculoskeletal Skin Diseases (award no. P30AR076316); and the Diversity and Health Disparities Award, which is funded by Cincinnati Children's Hospital Medical. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. P. Vega-Fernandez, MD, MSc, Y. Esteban, MD, M. Henrickson, MD, MPH, T.V. Ting, MD, MSc, Department of Pediatrics, University of Cincinnati, Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; E. Oberle, MD, Nationwide Children's Hospital, Columbus, Ohio, USA; J.P. Proulx-Gauthier, MD, FRCPC, Department of Pediatrics, CHU de Québec-Université Laval, Quebec City, Quebec, Canada; M. Clark, MD, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA; S. Shenoi, MBBS, MS, Seattle Children's Hospital and Research Center University of Washington, Seattle, Washington, USA; A. Thatayatikom, MD, AdventHealth for Children, Orlando, Florida, USA; H. Benham, DNP, APRN, Scottish Rite for Children Dallas, Dallas, Texas, USA; E.J. Brunner, DO, Geisinger Medical Center, Danville, Pennsylvania, USA; L. Woolnough, MD, MSCS, Department of Pediatrics, UFHealth, Gainesville, Florida, USA; L.R. Pratt, MD, University of Nebraska Medical Center, Omaha, Nebraska, USA; D. De Ranieri, MD, Department of Pediatrics, Northwestern Feinberg School of Medicine, Division of Rheumatology, Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois, USA; S. Hoffmann, MD, Children's Hospital of Richmond, Virginia, USA; G. Janow, MD, MPH, Joseph M. Sanzari Children's Hospital, Hackensack, New Jersey, USA; H. Bukulmez, MD, Department of Pediatrics, Division of Pediatric Rheumatology, Metro Health Medical System, Case Western Reserve University, Cleveland, Ohio, USA; M. Altaye, PhD, A. Cassedy, PhD, Department of Pediatrics, University of Cincinnati, Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; J. Roth, MD, PhD, FRCPC, Children's Hospital Eastern Ontario, Ottawa, Ontario, Canada. Address correspondence to Dr. P. Vega-Fernandez, 3333 Burnet Ave, Cincinnati, OH 45229, USA. Email: patricia.vegafernandez@cchmc.org. Accepted for publication September 13, 2022.
Jean-Philippe Proulx-Gauthier
The authors wish to acknowledge Childhood Arthritis and Rheumatology Research Alliance (CARRA) and the ongoing Arthritis Foundation financial support of CARRA. This project was funded by a CARRA–Arthritis Foundation Small Grant. PVF was supported by the Center for Clinical and Translational Science and Training at the University of Cincinnati, which is funded by the National Institutes of Health (NIH) Clinical and Translational Science Award program (grant 2UL1TR001425-05A1 and KL2 [2KL2TR001426-05A]); the National Institutes of Arthritis and Musculoskeletal Skin Diseases (award no. P30AR076316); and the Diversity and Health Disparities Award, which is funded by Cincinnati Children's Hospital Medical. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. P. Vega-Fernandez, MD, MSc, Y. Esteban, MD, M. Henrickson, MD, MPH, T.V. Ting, MD, MSc, Department of Pediatrics, University of Cincinnati, Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; E. Oberle, MD, Nationwide Children's Hospital, Columbus, Ohio, USA; J.P. Proulx-Gauthier, MD, FRCPC, Department of Pediatrics, CHU de Québec-Université Laval, Quebec City, Quebec, Canada; M. Clark, MD, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA; S. Shenoi, MBBS, MS, Seattle Children's Hospital and Research Center University of Washington, Seattle, Washington, USA; A. Thatayatikom, MD, AdventHealth for Children, Orlando, Florida, USA; H. Benham, DNP, APRN, Scottish Rite for Children Dallas, Dallas, Texas, USA; E.J. Brunner, DO, Geisinger Medical Center, Danville, Pennsylvania, USA; L. Woolnough, MD, MSCS, Department of Pediatrics, UFHealth, Gainesville, Florida, USA; L.R. Pratt, MD, University of Nebraska Medical Center, Omaha, Nebraska, USA; D. De Ranieri, MD, Department of Pediatrics, Northwestern Feinberg School of Medicine, Division of Rheumatology, Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois, USA; S. Hoffmann, MD, Children's Hospital of Richmond, Virginia, USA; G. Janow, MD, MPH, Joseph M. Sanzari Children's Hospital, Hackensack, New Jersey, USA; H. Bukulmez, MD, Department of Pediatrics, Division of Pediatric Rheumatology, Metro Health Medical System, Case Western Reserve University, Cleveland, Ohio, USA; M. Altaye, PhD, A. Cassedy, PhD, Department of Pediatrics, University of Cincinnati, Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; J. Roth, MD, PhD, FRCPC, Children's Hospital Eastern Ontario, Ottawa, Ontario, Canada. Address correspondence to Dr. P. Vega-Fernandez, 3333 Burnet Ave, Cincinnati, OH 45229, USA. Email: patricia.vegafernandez@cchmc.org. Accepted for publication September 13, 2022.
Matthew Clark
The authors wish to acknowledge Childhood Arthritis and Rheumatology Research Alliance (CARRA) and the ongoing Arthritis Foundation financial support of CARRA. This project was funded by a CARRA–Arthritis Foundation Small Grant. PVF was supported by the Center for Clinical and Translational Science and Training at the University of Cincinnati, which is funded by the National Institutes of Health (NIH) Clinical and Translational Science Award program (grant 2UL1TR001425-05A1 and KL2 [2KL2TR001426-05A]); the National Institutes of Arthritis and Musculoskeletal Skin Diseases (award no. P30AR076316); and the Diversity and Health Disparities Award, which is funded by Cincinnati Children's Hospital Medical. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. P. Vega-Fernandez, MD, MSc, Y. Esteban, MD, M. Henrickson, MD, MPH, T.V. Ting, MD, MSc, Department of Pediatrics, University of Cincinnati, Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; E. Oberle, MD, Nationwide Children's Hospital, Columbus, Ohio, USA; J.P. Proulx-Gauthier, MD, FRCPC, Department of Pediatrics, CHU de Québec-Université Laval, Quebec City, Quebec, Canada; M. Clark, MD, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA; S. Shenoi, MBBS, MS, Seattle Children's Hospital and Research Center University of Washington, Seattle, Washington, USA; A. Thatayatikom, MD, AdventHealth for Children, Orlando, Florida, USA; H. Benham, DNP, APRN, Scottish Rite for Children Dallas, Dallas, Texas, USA; E.J. Brunner, DO, Geisinger Medical Center, Danville, Pennsylvania, USA; L. Woolnough, MD, MSCS, Department of Pediatrics, UFHealth, Gainesville, Florida, USA; L.R. Pratt, MD, University of Nebraska Medical Center, Omaha, Nebraska, USA; D. De Ranieri, MD, Department of Pediatrics, Northwestern Feinberg School of Medicine, Division of Rheumatology, Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois, USA; S. Hoffmann, MD, Children's Hospital of Richmond, Virginia, USA; G. Janow, MD, MPH, Joseph M. Sanzari Children's Hospital, Hackensack, New Jersey, USA; H. Bukulmez, MD, Department of Pediatrics, Division of Pediatric Rheumatology, Metro Health Medical System, Case Western Reserve University, Cleveland, Ohio, USA; M. Altaye, PhD, A. Cassedy, PhD, Department of Pediatrics, University of Cincinnati, Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; J. Roth, MD, PhD, FRCPC, Children's Hospital Eastern Ontario, Ottawa, Ontario, Canada. Address correspondence to Dr. P. Vega-Fernandez, 3333 Burnet Ave, Cincinnati, OH 45229, USA. Email: patricia.vegafernandez@cchmc.org. Accepted for publication September 13, 2022.
Susan Shenoi
The authors wish to acknowledge Childhood Arthritis and Rheumatology Research Alliance (CARRA) and the ongoing Arthritis Foundation financial support of CARRA. This project was funded by a CARRA–Arthritis Foundation Small Grant. PVF was supported by the Center for Clinical and Translational Science and Training at the University of Cincinnati, which is funded by the National Institutes of Health (NIH) Clinical and Translational Science Award program (grant 2UL1TR001425-05A1 and KL2 [2KL2TR001426-05A]); the National Institutes of Arthritis and Musculoskeletal Skin Diseases (award no. P30AR076316); and the Diversity and Health Disparities Award, which is funded by Cincinnati Children's Hospital Medical. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. P. Vega-Fernandez, MD, MSc, Y. Esteban, MD, M. Henrickson, MD, MPH, T.V. Ting, MD, MSc, Department of Pediatrics, University of Cincinnati, Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; E. Oberle, MD, Nationwide Children's Hospital, Columbus, Ohio, USA; J.P. Proulx-Gauthier, MD, FRCPC, Department of Pediatrics, CHU de Québec-Université Laval, Quebec City, Quebec, Canada; M. Clark, MD, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA; S. Shenoi, MBBS, MS, Seattle Children's Hospital and Research Center University of Washington, Seattle, Washington, USA; A. Thatayatikom, MD, AdventHealth for Children, Orlando, Florida, USA; H. Benham, DNP, APRN, Scottish Rite for Children Dallas, Dallas, Texas, USA; E.J. Brunner, DO, Geisinger Medical Center, Danville, Pennsylvania, USA; L. Woolnough, MD, MSCS, Department of Pediatrics, UFHealth, Gainesville, Florida, USA; L.R. Pratt, MD, University of Nebraska Medical Center, Omaha, Nebraska, USA; D. De Ranieri, MD, Department of Pediatrics, Northwestern Feinberg School of Medicine, Division of Rheumatology, Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois, USA; S. Hoffmann, MD, Children's Hospital of Richmond, Virginia, USA; G. Janow, MD, MPH, Joseph M. Sanzari Children's Hospital, Hackensack, New Jersey, USA; H. Bukulmez, MD, Department of Pediatrics, Division of Pediatric Rheumatology, Metro Health Medical System, Case Western Reserve University, Cleveland, Ohio, USA; M. Altaye, PhD, A. Cassedy, PhD, Department of Pediatrics, University of Cincinnati, Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; J. Roth, MD, PhD, FRCPC, Children's Hospital Eastern Ontario, Ottawa, Ontario, Canada. Address correspondence to Dr. P. Vega-Fernandez, 3333 Burnet Ave, Cincinnati, OH 45229, USA. Email: patricia.vegafernandez@cchmc.org. Accepted for publication September 13, 2022.
Akaluck Thatayatikom
The authors wish to acknowledge Childhood Arthritis and Rheumatology Research Alliance (CARRA) and the ongoing Arthritis Foundation financial support of CARRA. This project was funded by a CARRA–Arthritis Foundation Small Grant. PVF was supported by the Center for Clinical and Translational Science and Training at the University of Cincinnati, which is funded by the National Institutes of Health (NIH) Clinical and Translational Science Award program (grant 2UL1TR001425-05A1 and KL2 [2KL2TR001426-05A]); the National Institutes of Arthritis and Musculoskeletal Skin Diseases (award no. P30AR076316); and the Diversity and Health Disparities Award, which is funded by Cincinnati Children's Hospital Medical. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. P. Vega-Fernandez, MD, MSc, Y. Esteban, MD, M. Henrickson, MD, MPH, T.V. Ting, MD, MSc, Department of Pediatrics, University of Cincinnati, Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; E. Oberle, MD, Nationwide Children's Hospital, Columbus, Ohio, USA; J.P. Proulx-Gauthier, MD, FRCPC, Department of Pediatrics, CHU de Québec-Université Laval, Quebec City, Quebec, Canada; M. Clark, MD, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA; S. Shenoi, MBBS, MS, Seattle Children's Hospital and Research Center University of Washington, Seattle, Washington, USA; A. Thatayatikom, MD, AdventHealth for Children, Orlando, Florida, USA; H. Benham, DNP, APRN, Scottish Rite for Children Dallas, Dallas, Texas, USA; E.J. Brunner, DO, Geisinger Medical Center, Danville, Pennsylvania, USA; L. Woolnough, MD, MSCS, Department of Pediatrics, UFHealth, Gainesville, Florida, USA; L.R. Pratt, MD, University of Nebraska Medical Center, Omaha, Nebraska, USA; D. De Ranieri, MD, Department of Pediatrics, Northwestern Feinberg School of Medicine, Division of Rheumatology, Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois, USA; S. Hoffmann, MD, Children's Hospital of Richmond, Virginia, USA; G. Janow, MD, MPH, Joseph M. Sanzari Children's Hospital, Hackensack, New Jersey, USA; H. Bukulmez, MD, Department of Pediatrics, Division of Pediatric Rheumatology, Metro Health Medical System, Case Western Reserve University, Cleveland, Ohio, USA; M. Altaye, PhD, A. Cassedy, PhD, Department of Pediatrics, University of Cincinnati, Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; J. Roth, MD, PhD, FRCPC, Children's Hospital Eastern Ontario, Ottawa, Ontario, Canada. Address correspondence to Dr. P. Vega-Fernandez, 3333 Burnet Ave, Cincinnati, OH 45229, USA. Email: patricia.vegafernandez@cchmc.org. Accepted for publication September 13, 2022.
Heather Benham
The authors wish to acknowledge Childhood Arthritis and Rheumatology Research Alliance (CARRA) and the ongoing Arthritis Foundation financial support of CARRA. This project was funded by a CARRA–Arthritis Foundation Small Grant. PVF was supported by the Center for Clinical and Translational Science and Training at the University of Cincinnati, which is funded by the National Institutes of Health (NIH) Clinical and Translational Science Award program (grant 2UL1TR001425-05A1 and KL2 [2KL2TR001426-05A]); the National Institutes of Arthritis and Musculoskeletal Skin Diseases (award no. P30AR076316); and the Diversity and Health Disparities Award, which is funded by Cincinnati Children's Hospital Medical. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. P. Vega-Fernandez, MD, MSc, Y. Esteban, MD, M. Henrickson, MD, MPH, T.V. Ting, MD, MSc, Department of Pediatrics, University of Cincinnati, Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; E. Oberle, MD, Nationwide Children's Hospital, Columbus, Ohio, USA; J.P. Proulx-Gauthier, MD, FRCPC, Department of Pediatrics, CHU de Québec-Université Laval, Quebec City, Quebec, Canada; M. Clark, MD, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA; S. Shenoi, MBBS, MS, Seattle Children's Hospital and Research Center University of Washington, Seattle, Washington, USA; A. Thatayatikom, MD, AdventHealth for Children, Orlando, Florida, USA; H. Benham, DNP, APRN, Scottish Rite for Children Dallas, Dallas, Texas, USA; E.J. Brunner, DO, Geisinger Medical Center, Danville, Pennsylvania, USA; L. Woolnough, MD, MSCS, Department of Pediatrics, UFHealth, Gainesville, Florida, USA; L.R. Pratt, MD, University of Nebraska Medical Center, Omaha, Nebraska, USA; D. De Ranieri, MD, Department of Pediatrics, Northwestern Feinberg School of Medicine, Division of Rheumatology, Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois, USA; S. Hoffmann, MD, Children's Hospital of Richmond, Virginia, USA; G. Janow, MD, MPH, Joseph M. Sanzari Children's Hospital, Hackensack, New Jersey, USA; H. Bukulmez, MD, Department of Pediatrics, Division of Pediatric Rheumatology, Metro Health Medical System, Case Western Reserve University, Cleveland, Ohio, USA; M. Altaye, PhD, A. Cassedy, PhD, Department of Pediatrics, University of Cincinnati, Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; J. Roth, MD, PhD, FRCPC, Children's Hospital Eastern Ontario, Ottawa, Ontario, Canada. Address correspondence to Dr. P. Vega-Fernandez, 3333 Burnet Ave, Cincinnati, OH 45229, USA. Email: patricia.vegafernandez@cchmc.org. Accepted for publication September 13, 2022.
Emily J. Brunner
The authors wish to acknowledge Childhood Arthritis and Rheumatology Research Alliance (CARRA) and the ongoing Arthritis Foundation financial support of CARRA. This project was funded by a CARRA–Arthritis Foundation Small Grant. PVF was supported by the Center for Clinical and Translational Science and Training at the University of Cincinnati, which is funded by the National Institutes of Health (NIH) Clinical and Translational Science Award program (grant 2UL1TR001425-05A1 and KL2 [2KL2TR001426-05A]); the National Institutes of Arthritis and Musculoskeletal Skin Diseases (award no. P30AR076316); and the Diversity and Health Disparities Award, which is funded by Cincinnati Children's Hospital Medical. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. P. Vega-Fernandez, MD, MSc, Y. Esteban, MD, M. Henrickson, MD, MPH, T.V. Ting, MD, MSc, Department of Pediatrics, University of Cincinnati, Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; E. Oberle, MD, Nationwide Children's Hospital, Columbus, Ohio, USA; J.P. Proulx-Gauthier, MD, FRCPC, Department of Pediatrics, CHU de Québec-Université Laval, Quebec City, Quebec, Canada; M. Clark, MD, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA; S. Shenoi, MBBS, MS, Seattle Children's Hospital and Research Center University of Washington, Seattle, Washington, USA; A. Thatayatikom, MD, AdventHealth for Children, Orlando, Florida, USA; H. Benham, DNP, APRN, Scottish Rite for Children Dallas, Dallas, Texas, USA; E.J. Brunner, DO, Geisinger Medical Center, Danville, Pennsylvania, USA; L. Woolnough, MD, MSCS, Department of Pediatrics, UFHealth, Gainesville, Florida, USA; L.R. Pratt, MD, University of Nebraska Medical Center, Omaha, Nebraska, USA; D. De Ranieri, MD, Department of Pediatrics, Northwestern Feinberg School of Medicine, Division of Rheumatology, Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois, USA; S. Hoffmann, MD, Children's Hospital of Richmond, Virginia, USA; G. Janow, MD, MPH, Joseph M. Sanzari Children's Hospital, Hackensack, New Jersey, USA; H. Bukulmez, MD, Department of Pediatrics, Division of Pediatric Rheumatology, Metro Health Medical System, Case Western Reserve University, Cleveland, Ohio, USA; M. Altaye, PhD, A. Cassedy, PhD, Department of Pediatrics, University of Cincinnati, Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; J. Roth, MD, PhD, FRCPC, Children's Hospital Eastern Ontario, Ottawa, Ontario, Canada. Address correspondence to Dr. P. Vega-Fernandez, 3333 Burnet Ave, Cincinnati, OH 45229, USA. Email: patricia.vegafernandez@cchmc.org. Accepted for publication September 13, 2022.
Leandra Woolnough
The authors wish to acknowledge Childhood Arthritis and Rheumatology Research Alliance (CARRA) and the ongoing Arthritis Foundation financial support of CARRA. This project was funded by a CARRA–Arthritis Foundation Small Grant. PVF was supported by the Center for Clinical and Translational Science and Training at the University of Cincinnati, which is funded by the National Institutes of Health (NIH) Clinical and Translational Science Award program (grant 2UL1TR001425-05A1 and KL2 [2KL2TR001426-05A]); the National Institutes of Arthritis and Musculoskeletal Skin Diseases (award no. P30AR076316); and the Diversity and Health Disparities Award, which is funded by Cincinnati Children's Hospital Medical. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. P. Vega-Fernandez, MD, MSc, Y. Esteban, MD, M. Henrickson, MD, MPH, T.V. Ting, MD, MSc, Department of Pediatrics, University of Cincinnati, Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; E. Oberle, MD, Nationwide Children's Hospital, Columbus, Ohio, USA; J.P. Proulx-Gauthier, MD, FRCPC, Department of Pediatrics, CHU de Québec-Université Laval, Quebec City, Quebec, Canada; M. Clark, MD, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA; S. Shenoi, MBBS, MS, Seattle Children's Hospital and Research Center University of Washington, Seattle, Washington, USA; A. Thatayatikom, MD, AdventHealth for Children, Orlando, Florida, USA; H. Benham, DNP, APRN, Scottish Rite for Children Dallas, Dallas, Texas, USA; E.J. Brunner, DO, Geisinger Medical Center, Danville, Pennsylvania, USA; L. Woolnough, MD, MSCS, Department of Pediatrics, UFHealth, Gainesville, Florida, USA; L.R. Pratt, MD, University of Nebraska Medical Center, Omaha, Nebraska, USA; D. De Ranieri, MD, Department of Pediatrics, Northwestern Feinberg School of Medicine, Division of Rheumatology, Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois, USA; S. Hoffmann, MD, Children's Hospital of Richmond, Virginia, USA; G. Janow, MD, MPH, Joseph M. Sanzari Children's Hospital, Hackensack, New Jersey, USA; H. Bukulmez, MD, Department of Pediatrics, Division of Pediatric Rheumatology, Metro Health Medical System, Case Western Reserve University, Cleveland, Ohio, USA; M. Altaye, PhD, A. Cassedy, PhD, Department of Pediatrics, University of Cincinnati, Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; J. Roth, MD, PhD, FRCPC, Children's Hospital Eastern Ontario, Ottawa, Ontario, Canada. Address correspondence to Dr. P. Vega-Fernandez, 3333 Burnet Ave, Cincinnati, OH 45229, USA. Email: patricia.vegafernandez@cchmc.org. Accepted for publication September 13, 2022.
Michael Henrickson
The authors wish to acknowledge Childhood Arthritis and Rheumatology Research Alliance (CARRA) and the ongoing Arthritis Foundation financial support of CARRA. This project was funded by a CARRA–Arthritis Foundation Small Grant. PVF was supported by the Center for Clinical and Translational Science and Training at the University of Cincinnati, which is funded by the National Institutes of Health (NIH) Clinical and Translational Science Award program (grant 2UL1TR001425-05A1 and KL2 [2KL2TR001426-05A]); the National Institutes of Arthritis and Musculoskeletal Skin Diseases (award no. P30AR076316); and the Diversity and Health Disparities Award, which is funded by Cincinnati Children's Hospital Medical. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. P. Vega-Fernandez, MD, MSc, Y. Esteban, MD, M. Henrickson, MD, MPH, T.V. Ting, MD, MSc, Department of Pediatrics, University of Cincinnati, Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; E. Oberle, MD, Nationwide Children's Hospital, Columbus, Ohio, USA; J.P. Proulx-Gauthier, MD, FRCPC, Department of Pediatrics, CHU de Québec-Université Laval, Quebec City, Quebec, Canada; M. Clark, MD, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA; S. Shenoi, MBBS, MS, Seattle Children's Hospital and Research Center University of Washington, Seattle, Washington, USA; A. Thatayatikom, MD, AdventHealth for Children, Orlando, Florida, USA; H. Benham, DNP, APRN, Scottish Rite for Children Dallas, Dallas, Texas, USA; E.J. Brunner, DO, Geisinger Medical Center, Danville, Pennsylvania, USA; L. Woolnough, MD, MSCS, Department of Pediatrics, UFHealth, Gainesville, Florida, USA; L.R. Pratt, MD, University of Nebraska Medical Center, Omaha, Nebraska, USA; D. De Ranieri, MD, Department of Pediatrics, Northwestern Feinberg School of Medicine, Division of Rheumatology, Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois, USA; S. Hoffmann, MD, Children's Hospital of Richmond, Virginia, USA; G. Janow, MD, MPH, Joseph M. Sanzari Children's Hospital, Hackensack, New Jersey, USA; H. Bukulmez, MD, Department of Pediatrics, Division of Pediatric Rheumatology, Metro Health Medical System, Case Western Reserve University, Cleveland, Ohio, USA; M. Altaye, PhD, A. Cassedy, PhD, Department of Pediatrics, University of Cincinnati, Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; J. Roth, MD, PhD, FRCPC, Children's Hospital Eastern Ontario, Ottawa, Ontario, Canada. Address correspondence to Dr. P. Vega-Fernandez, 3333 Burnet Ave, Cincinnati, OH 45229, USA. Email: patricia.vegafernandez@cchmc.org. Accepted for publication September 13, 2022.
Laura R. Pratt
The authors wish to acknowledge Childhood Arthritis and Rheumatology Research Alliance (CARRA) and the ongoing Arthritis Foundation financial support of CARRA. This project was funded by a CARRA–Arthritis Foundation Small Grant. PVF was supported by the Center for Clinical and Translational Science and Training at the University of Cincinnati, which is funded by the National Institutes of Health (NIH) Clinical and Translational Science Award program (grant 2UL1TR001425-05A1 and KL2 [2KL2TR001426-05A]); the National Institutes of Arthritis and Musculoskeletal Skin Diseases (award no. P30AR076316); and the Diversity and Health Disparities Award, which is funded by Cincinnati Children's Hospital Medical. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. P. Vega-Fernandez, MD, MSc, Y. Esteban, MD, M. Henrickson, MD, MPH, T.V. Ting, MD, MSc, Department of Pediatrics, University of Cincinnati, Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; E. Oberle, MD, Nationwide Children's Hospital, Columbus, Ohio, USA; J.P. Proulx-Gauthier, MD, FRCPC, Department of Pediatrics, CHU de Québec-Université Laval, Quebec City, Quebec, Canada; M. Clark, MD, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA; S. Shenoi, MBBS, MS, Seattle Children's Hospital and Research Center University of Washington, Seattle, Washington, USA; A. Thatayatikom, MD, AdventHealth for Children, Orlando, Florida, USA; H. Benham, DNP, APRN, Scottish Rite for Children Dallas, Dallas, Texas, USA; E.J. Brunner, DO, Geisinger Medical Center, Danville, Pennsylvania, USA; L. Woolnough, MD, MSCS, Department of Pediatrics, UFHealth, Gainesville, Florida, USA; L.R. Pratt, MD, University of Nebraska Medical Center, Omaha, Nebraska, USA; D. De Ranieri, MD, Department of Pediatrics, Northwestern Feinberg School of Medicine, Division of Rheumatology, Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois, USA; S. Hoffmann, MD, Children's Hospital of Richmond, Virginia, USA; G. Janow, MD, MPH, Joseph M. Sanzari Children's Hospital, Hackensack, New Jersey, USA; H. Bukulmez, MD, Department of Pediatrics, Division of Pediatric Rheumatology, Metro Health Medical System, Case Western Reserve University, Cleveland, Ohio, USA; M. Altaye, PhD, A. Cassedy, PhD, Department of Pediatrics, University of Cincinnati, Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; J. Roth, MD, PhD, FRCPC, Children's Hospital Eastern Ontario, Ottawa, Ontario, Canada. Address correspondence to Dr. P. Vega-Fernandez, 3333 Burnet Ave, Cincinnati, OH 45229, USA. Email: patricia.vegafernandez@cchmc.org. Accepted for publication September 13, 2022.
Deirdre De Ranieri
The authors wish to acknowledge Childhood Arthritis and Rheumatology Research Alliance (CARRA) and the ongoing Arthritis Foundation financial support of CARRA. This project was funded by a CARRA–Arthritis Foundation Small Grant. PVF was supported by the Center for Clinical and Translational Science and Training at the University of Cincinnati, which is funded by the National Institutes of Health (NIH) Clinical and Translational Science Award program (grant 2UL1TR001425-05A1 and KL2 [2KL2TR001426-05A]); the National Institutes of Arthritis and Musculoskeletal Skin Diseases (award no. P30AR076316); and the Diversity and Health Disparities Award, which is funded by Cincinnati Children's Hospital Medical. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. P. Vega-Fernandez, MD, MSc, Y. Esteban, MD, M. Henrickson, MD, MPH, T.V. Ting, MD, MSc, Department of Pediatrics, University of Cincinnati, Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; E. Oberle, MD, Nationwide Children's Hospital, Columbus, Ohio, USA; J.P. Proulx-Gauthier, MD, FRCPC, Department of Pediatrics, CHU de Québec-Université Laval, Quebec City, Quebec, Canada; M. Clark, MD, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA; S. Shenoi, MBBS, MS, Seattle Children's Hospital and Research Center University of Washington, Seattle, Washington, USA; A. Thatayatikom, MD, AdventHealth for Children, Orlando, Florida, USA; H. Benham, DNP, APRN, Scottish Rite for Children Dallas, Dallas, Texas, USA; E.J. Brunner, DO, Geisinger Medical Center, Danville, Pennsylvania, USA; L. Woolnough, MD, MSCS, Department of Pediatrics, UFHealth, Gainesville, Florida, USA; L.R. Pratt, MD, University of Nebraska Medical Center, Omaha, Nebraska, USA; D. De Ranieri, MD, Department of Pediatrics, Northwestern Feinberg School of Medicine, Division of Rheumatology, Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois, USA; S. Hoffmann, MD, Children's Hospital of Richmond, Virginia, USA; G. Janow, MD, MPH, Joseph M. Sanzari Children's Hospital, Hackensack, New Jersey, USA; H. Bukulmez, MD, Department of Pediatrics, Division of Pediatric Rheumatology, Metro Health Medical System, Case Western Reserve University, Cleveland, Ohio, USA; M. Altaye, PhD, A. Cassedy, PhD, Department of Pediatrics, University of Cincinnati, Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; J. Roth, MD, PhD, FRCPC, Children's Hospital Eastern Ontario, Ottawa, Ontario, Canada. Address correspondence to Dr. P. Vega-Fernandez, 3333 Burnet Ave, Cincinnati, OH 45229, USA. Email: patricia.vegafernandez@cchmc.org. Accepted for publication September 13, 2022.
Sarah Hoffmann
The authors wish to acknowledge Childhood Arthritis and Rheumatology Research Alliance (CARRA) and the ongoing Arthritis Foundation financial support of CARRA. This project was funded by a CARRA–Arthritis Foundation Small Grant. PVF was supported by the Center for Clinical and Translational Science and Training at the University of Cincinnati, which is funded by the National Institutes of Health (NIH) Clinical and Translational Science Award program (grant 2UL1TR001425-05A1 and KL2 [2KL2TR001426-05A]); the National Institutes of Arthritis and Musculoskeletal Skin Diseases (award no. P30AR076316); and the Diversity and Health Disparities Award, which is funded by Cincinnati Children's Hospital Medical. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. P. Vega-Fernandez, MD, MSc, Y. Esteban, MD, M. Henrickson, MD, MPH, T.V. Ting, MD, MSc, Department of Pediatrics, University of Cincinnati, Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; E. Oberle, MD, Nationwide Children's Hospital, Columbus, Ohio, USA; J.P. Proulx-Gauthier, MD, FRCPC, Department of Pediatrics, CHU de Québec-Université Laval, Quebec City, Quebec, Canada; M. Clark, MD, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA; S. Shenoi, MBBS, MS, Seattle Children's Hospital and Research Center University of Washington, Seattle, Washington, USA; A. Thatayatikom, MD, AdventHealth for Children, Orlando, Florida, USA; H. Benham, DNP, APRN, Scottish Rite for Children Dallas, Dallas, Texas, USA; E.J. Brunner, DO, Geisinger Medical Center, Danville, Pennsylvania, USA; L. Woolnough, MD, MSCS, Department of Pediatrics, UFHealth, Gainesville, Florida, USA; L.R. Pratt, MD, University of Nebraska Medical Center, Omaha, Nebraska, USA; D. De Ranieri, MD, Department of Pediatrics, Northwestern Feinberg School of Medicine, Division of Rheumatology, Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois, USA; S. Hoffmann, MD, Children's Hospital of Richmond, Virginia, USA; G. Janow, MD, MPH, Joseph M. Sanzari Children's Hospital, Hackensack, New Jersey, USA; H. Bukulmez, MD, Department of Pediatrics, Division of Pediatric Rheumatology, Metro Health Medical System, Case Western Reserve University, Cleveland, Ohio, USA; M. Altaye, PhD, A. Cassedy, PhD, Department of Pediatrics, University of Cincinnati, Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; J. Roth, MD, PhD, FRCPC, Children's Hospital Eastern Ontario, Ottawa, Ontario, Canada. Address correspondence to Dr. P. Vega-Fernandez, 3333 Burnet Ave, Cincinnati, OH 45229, USA. Email: patricia.vegafernandez@cchmc.org. Accepted for publication September 13, 2022.
Ginger Janow
The authors wish to acknowledge Childhood Arthritis and Rheumatology Research Alliance (CARRA) and the ongoing Arthritis Foundation financial support of CARRA. This project was funded by a CARRA–Arthritis Foundation Small Grant. PVF was supported by the Center for Clinical and Translational Science and Training at the University of Cincinnati, which is funded by the National Institutes of Health (NIH) Clinical and Translational Science Award program (grant 2UL1TR001425-05A1 and KL2 [2KL2TR001426-05A]); the National Institutes of Arthritis and Musculoskeletal Skin Diseases (award no. P30AR076316); and the Diversity and Health Disparities Award, which is funded by Cincinnati Children's Hospital Medical. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. P. Vega-Fernandez, MD, MSc, Y. Esteban, MD, M. Henrickson, MD, MPH, T.V. Ting, MD, MSc, Department of Pediatrics, University of Cincinnati, Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; E. Oberle, MD, Nationwide Children's Hospital, Columbus, Ohio, USA; J.P. Proulx-Gauthier, MD, FRCPC, Department of Pediatrics, CHU de Québec-Université Laval, Quebec City, Quebec, Canada; M. Clark, MD, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA; S. Shenoi, MBBS, MS, Seattle Children's Hospital and Research Center University of Washington, Seattle, Washington, USA; A. Thatayatikom, MD, AdventHealth for Children, Orlando, Florida, USA; H. Benham, DNP, APRN, Scottish Rite for Children Dallas, Dallas, Texas, USA; E.J. Brunner, DO, Geisinger Medical Center, Danville, Pennsylvania, USA; L. Woolnough, MD, MSCS, Department of Pediatrics, UFHealth, Gainesville, Florida, USA; L.R. Pratt, MD, University of Nebraska Medical Center, Omaha, Nebraska, USA; D. De Ranieri, MD, Department of Pediatrics, Northwestern Feinberg School of Medicine, Division of Rheumatology, Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois, USA; S. Hoffmann, MD, Children's Hospital of Richmond, Virginia, USA; G. Janow, MD, MPH, Joseph M. Sanzari Children's Hospital, Hackensack, New Jersey, USA; H. Bukulmez, MD, Department of Pediatrics, Division of Pediatric Rheumatology, Metro Health Medical System, Case Western Reserve University, Cleveland, Ohio, USA; M. Altaye, PhD, A. Cassedy, PhD, Department of Pediatrics, University of Cincinnati, Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; J. Roth, MD, PhD, FRCPC, Children's Hospital Eastern Ontario, Ottawa, Ontario, Canada. Address correspondence to Dr. P. Vega-Fernandez, 3333 Burnet Ave, Cincinnati, OH 45229, USA. Email: patricia.vegafernandez@cchmc.org. Accepted for publication September 13, 2022.
Hulya Bukulmez
The authors wish to acknowledge Childhood Arthritis and Rheumatology Research Alliance (CARRA) and the ongoing Arthritis Foundation financial support of CARRA. This project was funded by a CARRA–Arthritis Foundation Small Grant. PVF was supported by the Center for Clinical and Translational Science and Training at the University of Cincinnati, which is funded by the National Institutes of Health (NIH) Clinical and Translational Science Award program (grant 2UL1TR001425-05A1 and KL2 [2KL2TR001426-05A]); the National Institutes of Arthritis and Musculoskeletal Skin Diseases (award no. P30AR076316); and the Diversity and Health Disparities Award, which is funded by Cincinnati Children's Hospital Medical. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. P. Vega-Fernandez, MD, MSc, Y. Esteban, MD, M. Henrickson, MD, MPH, T.V. Ting, MD, MSc, Department of Pediatrics, University of Cincinnati, Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; E. Oberle, MD, Nationwide Children's Hospital, Columbus, Ohio, USA; J.P. Proulx-Gauthier, MD, FRCPC, Department of Pediatrics, CHU de Québec-Université Laval, Quebec City, Quebec, Canada; M. Clark, MD, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA; S. Shenoi, MBBS, MS, Seattle Children's Hospital and Research Center University of Washington, Seattle, Washington, USA; A. Thatayatikom, MD, AdventHealth for Children, Orlando, Florida, USA; H. Benham, DNP, APRN, Scottish Rite for Children Dallas, Dallas, Texas, USA; E.J. Brunner, DO, Geisinger Medical Center, Danville, Pennsylvania, USA; L. Woolnough, MD, MSCS, Department of Pediatrics, UFHealth, Gainesville, Florida, USA; L.R. Pratt, MD, University of Nebraska Medical Center, Omaha, Nebraska, USA; D. De Ranieri, MD, Department of Pediatrics, Northwestern Feinberg School of Medicine, Division of Rheumatology, Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois, USA; S. Hoffmann, MD, Children's Hospital of Richmond, Virginia, USA; G. Janow, MD, MPH, Joseph M. Sanzari Children's Hospital, Hackensack, New Jersey, USA; H. Bukulmez, MD, Department of Pediatrics, Division of Pediatric Rheumatology, Metro Health Medical System, Case Western Reserve University, Cleveland, Ohio, USA; M. Altaye, PhD, A. Cassedy, PhD, Department of Pediatrics, University of Cincinnati, Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; J. Roth, MD, PhD, FRCPC, Children's Hospital Eastern Ontario, Ottawa, Ontario, Canada. Address correspondence to Dr. P. Vega-Fernandez, 3333 Burnet Ave, Cincinnati, OH 45229, USA. Email: patricia.vegafernandez@cchmc.org. Accepted for publication September 13, 2022.
Mekibib Altaye
The authors wish to acknowledge Childhood Arthritis and Rheumatology Research Alliance (CARRA) and the ongoing Arthritis Foundation financial support of CARRA. This project was funded by a CARRA–Arthritis Foundation Small Grant. PVF was supported by the Center for Clinical and Translational Science and Training at the University of Cincinnati, which is funded by the National Institutes of Health (NIH) Clinical and Translational Science Award program (grant 2UL1TR001425-05A1 and KL2 [2KL2TR001426-05A]); the National Institutes of Arthritis and Musculoskeletal Skin Diseases (award no. P30AR076316); and the Diversity and Health Disparities Award, which is funded by Cincinnati Children's Hospital Medical. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. P. Vega-Fernandez, MD, MSc, Y. Esteban, MD, M. Henrickson, MD, MPH, T.V. Ting, MD, MSc, Department of Pediatrics, University of Cincinnati, Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; E. Oberle, MD, Nationwide Children's Hospital, Columbus, Ohio, USA; J.P. Proulx-Gauthier, MD, FRCPC, Department of Pediatrics, CHU de Québec-Université Laval, Quebec City, Quebec, Canada; M. Clark, MD, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA; S. Shenoi, MBBS, MS, Seattle Children's Hospital and Research Center University of Washington, Seattle, Washington, USA; A. Thatayatikom, MD, AdventHealth for Children, Orlando, Florida, USA; H. Benham, DNP, APRN, Scottish Rite for Children Dallas, Dallas, Texas, USA; E.J. Brunner, DO, Geisinger Medical Center, Danville, Pennsylvania, USA; L. Woolnough, MD, MSCS, Department of Pediatrics, UFHealth, Gainesville, Florida, USA; L.R. Pratt, MD, University of Nebraska Medical Center, Omaha, Nebraska, USA; D. De Ranieri, MD, Department of Pediatrics, Northwestern Feinberg School of Medicine, Division of Rheumatology, Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois, USA; S. Hoffmann, MD, Children's Hospital of Richmond, Virginia, USA; G. Janow, MD, MPH, Joseph M. Sanzari Children's Hospital, Hackensack, New Jersey, USA; H. Bukulmez, MD, Department of Pediatrics, Division of Pediatric Rheumatology, Metro Health Medical System, Case Western Reserve University, Cleveland, Ohio, USA; M. Altaye, PhD, A. Cassedy, PhD, Department of Pediatrics, University of Cincinnati, Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; J. Roth, MD, PhD, FRCPC, Children's Hospital Eastern Ontario, Ottawa, Ontario, Canada. Address correspondence to Dr. P. Vega-Fernandez, 3333 Burnet Ave, Cincinnati, OH 45229, USA. Email: patricia.vegafernandez@cchmc.org. Accepted for publication September 13, 2022.
Amy Cassedy
The authors wish to acknowledge Childhood Arthritis and Rheumatology Research Alliance (CARRA) and the ongoing Arthritis Foundation financial support of CARRA. This project was funded by a CARRA–Arthritis Foundation Small Grant. PVF was supported by the Center for Clinical and Translational Science and Training at the University of Cincinnati, which is funded by the National Institutes of Health (NIH) Clinical and Translational Science Award program (grant 2UL1TR001425-05A1 and KL2 [2KL2TR001426-05A]); the National Institutes of Arthritis and Musculoskeletal Skin Diseases (award no. P30AR076316); and the Diversity and Health Disparities Award, which is funded by Cincinnati Children's Hospital Medical. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. P. Vega-Fernandez, MD, MSc, Y. Esteban, MD, M. Henrickson, MD, MPH, T.V. Ting, MD, MSc, Department of Pediatrics, University of Cincinnati, Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; E. Oberle, MD, Nationwide Children's Hospital, Columbus, Ohio, USA; J.P. Proulx-Gauthier, MD, FRCPC, Department of Pediatrics, CHU de Québec-Université Laval, Quebec City, Quebec, Canada; M. Clark, MD, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA; S. Shenoi, MBBS, MS, Seattle Children's Hospital and Research Center University of Washington, Seattle, Washington, USA; A. Thatayatikom, MD, AdventHealth for Children, Orlando, Florida, USA; H. Benham, DNP, APRN, Scottish Rite for Children Dallas, Dallas, Texas, USA; E.J. Brunner, DO, Geisinger Medical Center, Danville, Pennsylvania, USA; L. Woolnough, MD, MSCS, Department of Pediatrics, UFHealth, Gainesville, Florida, USA; L.R. Pratt, MD, University of Nebraska Medical Center, Omaha, Nebraska, USA; D. De Ranieri, MD, Department of Pediatrics, Northwestern Feinberg School of Medicine, Division of Rheumatology, Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois, USA; S. Hoffmann, MD, Children's Hospital of Richmond, Virginia, USA; G. Janow, MD, MPH, Joseph M. Sanzari Children's Hospital, Hackensack, New Jersey, USA; H. Bukulmez, MD, Department of Pediatrics, Division of Pediatric Rheumatology, Metro Health Medical System, Case Western Reserve University, Cleveland, Ohio, USA; M. Altaye, PhD, A. Cassedy, PhD, Department of Pediatrics, University of Cincinnati, Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; J. Roth, MD, PhD, FRCPC, Children's Hospital Eastern Ontario, Ottawa, Ontario, Canada. Address correspondence to Dr. P. Vega-Fernandez, 3333 Burnet Ave, Cincinnati, OH 45229, USA. Email: patricia.vegafernandez@cchmc.org. Accepted for publication September 13, 2022.
Tracy V. Ting
The authors wish to acknowledge Childhood Arthritis and Rheumatology Research Alliance (CARRA) and the ongoing Arthritis Foundation financial support of CARRA. This project was funded by a CARRA–Arthritis Foundation Small Grant. PVF was supported by the Center for Clinical and Translational Science and Training at the University of Cincinnati, which is funded by the National Institutes of Health (NIH) Clinical and Translational Science Award program (grant 2UL1TR001425-05A1 and KL2 [2KL2TR001426-05A]); the National Institutes of Arthritis and Musculoskeletal Skin Diseases (award no. P30AR076316); and the Diversity and Health Disparities Award, which is funded by Cincinnati Children's Hospital Medical. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. P. Vega-Fernandez, MD, MSc, Y. Esteban, MD, M. Henrickson, MD, MPH, T.V. Ting, MD, MSc, Department of Pediatrics, University of Cincinnati, Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; E. Oberle, MD, Nationwide Children's Hospital, Columbus, Ohio, USA; J.P. Proulx-Gauthier, MD, FRCPC, Department of Pediatrics, CHU de Québec-Université Laval, Quebec City, Quebec, Canada; M. Clark, MD, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA; S. Shenoi, MBBS, MS, Seattle Children's Hospital and Research Center University of Washington, Seattle, Washington, USA; A. Thatayatikom, MD, AdventHealth for Children, Orlando, Florida, USA; H. Benham, DNP, APRN, Scottish Rite for Children Dallas, Dallas, Texas, USA; E.J. Brunner, DO, Geisinger Medical Center, Danville, Pennsylvania, USA; L. Woolnough, MD, MSCS, Department of Pediatrics, UFHealth, Gainesville, Florida, USA; L.R. Pratt, MD, University of Nebraska Medical Center, Omaha, Nebraska, USA; D. De Ranieri, MD, Department of Pediatrics, Northwestern Feinberg School of Medicine, Division of Rheumatology, Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois, USA; S. Hoffmann, MD, Children's Hospital of Richmond, Virginia, USA; G. Janow, MD, MPH, Joseph M. Sanzari Children's Hospital, Hackensack, New Jersey, USA; H. Bukulmez, MD, Department of Pediatrics, Division of Pediatric Rheumatology, Metro Health Medical System, Case Western Reserve University, Cleveland, Ohio, USA; M. Altaye, PhD, A. Cassedy, PhD, Department of Pediatrics, University of Cincinnati, Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; J. Roth, MD, PhD, FRCPC, Children's Hospital Eastern Ontario, Ottawa, Ontario, Canada. Address correspondence to Dr. P. Vega-Fernandez, 3333 Burnet Ave, Cincinnati, OH 45229, USA. Email: patricia.vegafernandez@cchmc.org. Accepted for publication September 13, 2022.
Johannes Roth
The authors wish to acknowledge Childhood Arthritis and Rheumatology Research Alliance (CARRA) and the ongoing Arthritis Foundation financial support of CARRA. This project was funded by a CARRA–Arthritis Foundation Small Grant. PVF was supported by the Center for Clinical and Translational Science and Training at the University of Cincinnati, which is funded by the National Institutes of Health (NIH) Clinical and Translational Science Award program (grant 2UL1TR001425-05A1 and KL2 [2KL2TR001426-05A]); the National Institutes of Arthritis and Musculoskeletal Skin Diseases (award no. P30AR076316); and the Diversity and Health Disparities Award, which is funded by Cincinnati Children's Hospital Medical. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. P. Vega-Fernandez, MD, MSc, Y. Esteban, MD, M. Henrickson, MD, MPH, T.V. Ting, MD, MSc, Department of Pediatrics, University of Cincinnati, Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; E. Oberle, MD, Nationwide Children's Hospital, Columbus, Ohio, USA; J.P. Proulx-Gauthier, MD, FRCPC, Department of Pediatrics, CHU de Québec-Université Laval, Quebec City, Quebec, Canada; M. Clark, MD, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA; S. Shenoi, MBBS, MS, Seattle Children's Hospital and Research Center University of Washington, Seattle, Washington, USA; A. Thatayatikom, MD, AdventHealth for Children, Orlando, Florida, USA; H. Benham, DNP, APRN, Scottish Rite for Children Dallas, Dallas, Texas, USA; E.J. Brunner, DO, Geisinger Medical Center, Danville, Pennsylvania, USA; L. Woolnough, MD, MSCS, Department of Pediatrics, UFHealth, Gainesville, Florida, USA; L.R. Pratt, MD, University of Nebraska Medical Center, Omaha, Nebraska, USA; D. De Ranieri, MD, Department of Pediatrics, Northwestern Feinberg School of Medicine, Division of Rheumatology, Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois, USA; S. Hoffmann, MD, Children's Hospital of Richmond, Virginia, USA; G. Janow, MD, MPH, Joseph M. Sanzari Children's Hospital, Hackensack, New Jersey, USA; H. Bukulmez, MD, Department of Pediatrics, Division of Pediatric Rheumatology, Metro Health Medical System, Case Western Reserve University, Cleveland, Ohio, USA; M. Altaye, PhD, A. Cassedy, PhD, Department of Pediatrics, University of Cincinnati, Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; J. Roth, MD, PhD, FRCPC, Children's Hospital Eastern Ontario, Ottawa, Ontario, Canada. Address correspondence to Dr. P. Vega-Fernandez, 3333 Burnet Ave, Cincinnati, OH 45229, USA. Email: patricia.vegafernandez@cchmc.org. Accepted for publication September 13, 2022.
Article Figures & Data
Additional Files
DataSuppl
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Reliability of the Pediatric Specific Musculoskeletal Ultrasound Scoring Systems for the Elbow, Wrist, and Finger Joints
Patricia Vega-Fernandez, Ysabella Esteban, Edward Oberle, Jean-Philippe Proulx-Gauthier, Matthew Clark, Susan Shenoi, Akaluck Thatayatikom, Heather Benham, Emily J. Brunner, Leandra Woolnough, Michael Henrickson, Laura R. Pratt, Deirdre De Ranieri, Sarah Hoffmann, Ginger Janow, Hulya Bukulmez, Mekibib Altaye, Amy Cassedy, Tracy V. Ting, Johannes Roth
The Journal of Rheumatology Oct 2022, jrheum.220382; DOI: 10.3899/jrheum.220382
Reliability of the Pediatric Specific Musculoskeletal Ultrasound Scoring Systems for the Elbow, Wrist, and Finger Joints
Patricia Vega-Fernandez, Ysabella Esteban, Edward Oberle, Jean-Philippe Proulx-Gauthier, Matthew Clark, Susan Shenoi, Akaluck Thatayatikom, Heather Benham, Emily J. Brunner, Leandra Woolnough, Michael Henrickson, Laura R. Pratt, Deirdre De Ranieri, Sarah Hoffmann, Ginger Janow, Hulya Bukulmez, Mekibib Altaye, Amy Cassedy, Tracy V. Ting, Johannes Roth
The Journal of Rheumatology Oct 2022, jrheum.220382; DOI: 10.3899/jrheum.220382